Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / AH Bio Fund IV, L.P.

AH Bio Fund IV, L.P.

Active deploymentClosed to new capitalFundADV: Venture Capital FundAndreessen HorowitzDelaware
Amounts, each with its basis
Vintage
2022basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$1.5Bwhat may be sold, not what was raised; file 021-430407, sworn by the adviser or filed under this vehicle
Form D sold
$1.5Bas of the filing of Jan 21, 2022, 149 investors
First sale
Jan 7, 2022
Reported GAV
$1.5Bon the Form ADV filed Mar 29, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
150
Reported on ADV
Mar 31, 2023 to Mar 29, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2022-01-21: the stated $1.5bn offering reported fully sold (fr-1)
evidence dated Jan 21, 2022. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Active deployment
vintage 2 to 4 years
age years: 4first sale: 2022-01-07vintage year: $2,022adv gav as of: 2024-03-29vintage basis: form_d_first_saleform d sold usd: $1.5Bform d offering usd: $1.5Bform d latest filed at: 2022-01-21
The fund's own reporting through time
4 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 31, 2023Venture Capital Fund$1.5B
1520%yes
Mar 31, 2023Venture Capital Fund$1.5B
1520%yes
May 1, 2023Venture Capital Fund$1.5B
1520%yes
Mar 29, 2024Venture Capital Fund$1.5B
1501%yes
Principals and agents
2 principals on Form D, 0 placement agents
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Mar 31, 2023
    AH Bio Fund IV, L.P. first reported on Form ADV by Andreessen Horowitz (Venture Capital Fund), GAV $1,489,117,353
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Jan 21, 2022
    AH Bio Fund IV, L.P. filed Form D: $1,500,000,000 sold of $1,500,000,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this vehicle